FOXO1 may negatively regulate human fetal islet β-cell differentiation by regulating the crucial transcription factors NGN3 and NKX6-1, and the manipulation of FOXO1 levels may be a valuable tool for improving cellular diabetes treatment strategies [14]. The gene discussed is FOXO1; the disease is diabetes mellitus.